lymphoproliferative disorder
Showing 1 - 25 of 48
Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and
Recruiting
- Lymphomatoid Granulomatosis
- +3 more
- Interferon
- Rituxan and EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)
Recruiting
- Epstein-Barr Virus Infections
- +3 more
- Nivolumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Project: Every Child for Younger Patients With Cancer
Recruiting
- Carcinoma In Situ
- +10 more
- Cytology Specimen Collection Procedure
- Medical Chart Review
-
Birmingham, Alabama
- +240 more
Oct 19, 2022
Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,
Active, not recruiting
- Lymphoproliferative Disorder
- +3 more
- Etoposide
- +13 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Collecting and Storing Tissue Samples From Rare or Cutaneous
Active, not recruiting
- Adult Immunoblastic Lymphoma
- +12 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +129 more
Mar 23, 2022
Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +13 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Feb 8, 2022
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,
Recruiting
- Grade 1 Follicular Lymphoma
- +7 more
- Acalabrutinib
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 7, 2021
Tissue, Blood, and Body Fluid Sample Collection From Hematologic
Recruiting
- Chronic Myeloproliferative Disorders
- +7 more
- biologic sample preservation procedure
- cytology specimen collection procedure
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Oct 14, 2021
Collecting and Storing Blood Samples From Patients With Cancer
Withdrawn
- Brain and Central Nervous System Tumors
- +10 more
- (no location specified)
Sep 20, 2021
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)
Completed
- Brain and Central Nervous System Tumors
- +10 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Spartanburg, Houston (methadone HCl, morphine
Terminated
- Brain and Central Nervous System Tumors
- +10 more
- methadone hydrochloride
- +2 more
-
Spartanburg, South Carolina
- +1 more
Sep 1, 2020
Anemia, Leukemia, Lymphoma Trial in Los Angeles (darbepoetin alfa, epoetin alfa)
Completed
- Anemia
- +6 more
- darbepoetin alfa
- epoetin alfa
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020
Lymphoma, Lymphoproliferative Disorder Trial in Los Angeles (bortezomib + ganciclovir)
Terminated
- Lymphoma
- Lymphoproliferative Disorder
- bortezomib + ganciclovir
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit, Cleveland, Philadelphia (educational
Completed
- Brain and Central Nervous System Tumors
- +8 more
- educational intervention
-
Detroit, Michigan
- +3 more
Jul 23, 2020
Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Lymphoproliferative Disorder Trial in Houston (LMP specific T cells)
Completed
- Hodgkin Lymphoma
- +5 more
- LMP specific T cells
-
Houston, Texas
- +1 more
Feb 5, 2020
Lymphoproliferative Disorder Trial in Worldwide (rituximab, cyclophosphamide, methylprednisolone)
Completed
- Lymphoproliferative Disorder
- rituximab
- +3 more
-
Birmingham, Alabama
- +77 more
Jul 25, 2019
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Detroit (biological, drug, other, procedure)
Terminated
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +7 more
-
Detroit, MichiganKarmanos Cancer Institute
Mar 13, 2019
Lymphoproliferative Disorder Trial in Baltimore (Inactivated EBV-infected vaccine)
Terminated
- Lymphoproliferative Disorder
- Inactivated EBV-infected vaccine
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 5, 2019
Brain and CNS Tumors, Lymphoma, Lymphoproliferative Disorder Trial in Dallas (biological, drug, radiation)
Withdrawn
- Brain and Central Nervous System Tumors
- +3 more
- autologous immunoglobulin idiotype-KLH conjugate vaccine
- +4 more
-
Dallas, TexasSimmons Comprehensive Cancer Center at University of Texas South
Nov 21, 2018
Non-Hodgkins Lymphoma, Hodgkins Lymphoma, Lymphoproliferative Disorder Trial in Washington, Valhalla (EBV CTL's, Peripheral
Completed
- Non-Hodgkins Lymphoma
- +2 more
- EBV CTL's
- Peripheral Blood Donor
-
Washington, District of Columbia
- +1 more
Dec 20, 2017
Lymphoproliferative Disorder Trial in Minneapolis, Saint Louis (rituximab, bortezomib)
Terminated
- Lymphoproliferative Disorder
- rituximab
- bortezomib
-
Minneapolis, Minnesota
- +1 more
Dec 3, 2017
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (baclofen/amitriptyline/ketamine gel, )
Completed
- Chronic Myeloproliferative Disorders
- +9 more
- baclofen/amitriptyline/ketamine gel
- placebo
-
Scottsdale, Arizona
- +164 more
Jul 25, 2017
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Winston-Salem (music therapy)
Completed
- Chronic Myeloproliferative Disorders
- +9 more
- music therapy
-
Winston-Salem, North CarolinaWake Forest University Comprehensive Cancer Center
May 25, 2017